QR Kodea

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants

SARS-CoV-2 has caused the COVID-19 pandemic since early 2020. As of January 2022, the worldwide spreading of SARS-CoV-2 leads to approximately 0.35 billion of human infections and five millions of deaths. Current vaccination is one of the effective ways to control SARS-CoV-2 transmission and reduce...

Deskribapen osoa

Gorde:
Egile Nagusiak: Joy-Yan Lam, Yau-Yee Ng, Chun-Kit Yuen, Wan-Man Wong, Kwok-Yung Yuen, Kin-Hang Kok
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis Group 2022-12-01
Saila:Emerging Microbes and Infections
Gaiak:
COVID-19
SARS-CoV-2
nasal protein vaccine booster
delta variant
omicron variant
Sarrera elektronikoa:https://www.tandfonline.com/doi/10.1080/22221751.2022.2053365
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak